GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Clinical trials for GPC3 POSITIVE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GPC3 POSITIVE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for GPC3 POSITIVE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Super' cell therapy tested for tough liver cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of personalized cell therapy for patients with advanced liver cancer. The therapy, called 'Super CAR-T,' involves modifying a patient's own immune cells to target a specific protein (GPC3) found on their cancer cells. The mai…
Matched conditions: GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cell therapy tested for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called TC-G203 for people with advanced solid tumors that have returned or spread. The main goal is to find the safest dose and see how well the body handles the treatment. It is for patients whose cancer has a specific marker …
Matched conditions: GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC